tiprankstipranks
Advertisement
Advertisement

TYRA Stock Latest News

Tyra Biosciences price target raised to $56 from $42 at Piper Sandler
The FlyTyra Biosciences price target raised to $56 from $42 at Piper Sandler
7d ago
TYRA
Tyra Bioscience Raises $126 Million in Block Share Sale
PremiumCompany Announcements
Tyra Bioscience Raises $126 Million in Block Share Sale
22d ago
8K
TYRA
Tyra Biosciences: FGFR3-Focused Pipeline and Upcoming Clinical Catalysts Support Buy Rating and Favorable Risk‑Reward
PremiumRatings
Tyra Biosciences: FGFR3-Focused Pipeline and Upcoming Clinical Catalysts Support Buy Rating and Favorable Risk‑Reward
24d ago
TYRA
Tyra Biosciences reports Q4 EPS (57c), consensus (53c)
PremiumThe Fly
Tyra Biosciences reports Q4 EPS (57c), consensus (53c)
24d ago
TYRA
Short Report: Under Armour short interest at five-month lows
PremiumThe Fly
Short Report: Under Armour short interest at five-month lows
27d ago
UA
RDW
Tyra Biosciences initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyTyra Biosciences initiated with an Overweight at Cantor Fitzgerald
1M ago
TYRA
Tyra Biosciences initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Tyra Biosciences initiated with an Overweight at Cantor Fitzgerald
1M ago
TYRA
Tyra Biosciences price target raised to $45 from $30 at H.C. Wainwright
Premium
The Fly
Tyra Biosciences price target raised to $45 from $30 at H.C. Wainwright
1M ago
TYRA
Buy Rating on Tyra Biosciences Driven by Dabogratinib’s Differentiated FGFR3 Profile and Key Near-Term Phase II Catalyst
PremiumRatings
Buy Rating on Tyra Biosciences Driven by Dabogratinib’s Differentiated FGFR3 Profile and Key Near-Term Phase II Catalyst
1M ago
TYRA
Tyra Biosciences Advances TYRA-300 Bladder Cancer Trial: What Investors Should Watch
PremiumCompany Announcements
Tyra Biosciences Advances TYRA-300 Bladder Cancer Trial: What Investors Should Watch
1M ago
TYRA
Tyra Biosciences price target raised to $53 from $37 at Wedbush
PremiumThe Fly
Tyra Biosciences price target raised to $53 from $37 at Wedbush
1M ago
BBIO
TYRA
Tyra Biosciences participates in a coferejce call with William Blair
PremiumThe Fly
Tyra Biosciences participates in a coferejce call with William Blair
1M ago
TYRA
Tyra Biosciences initiated with an Outperform at William Blair
PremiumThe FlyTyra Biosciences initiated with an Outperform at William Blair
1M ago
TYRA
Tyra Biosciences Advances BEACH301 Dose Escalation
Premium
Company Announcements
Tyra Biosciences Advances BEACH301 Dose Escalation
2M ago
TYRA
Tyra Biosciences price target raised to $50 from $36 at Oppenheimer
Premium
The Fly
Tyra Biosciences price target raised to $50 from $36 at Oppenheimer
2M ago
TYRA
Tyra Biosciences initiated with an Overweight at Barclays
PremiumThe Fly
Tyra Biosciences initiated with an Overweight at Barclays
2M ago
TYRA
Tyra Biosciences price target raised to $42 from $33 at Piper Sandler
PremiumThe Fly
Tyra Biosciences price target raised to $42 from $33 at Piper Sandler
2M ago
TYRA
Wedbush raises price target on Tyra Biosciences, adds to Best Ideas List
PremiumThe Fly
Wedbush raises price target on Tyra Biosciences, adds to Best Ideas List
3M ago
TYRA
Tyra Biosciences initiated as Early-Stage Biotech at Goldman Sachs
PremiumThe Fly
Tyra Biosciences initiated as Early-Stage Biotech at Goldman Sachs
4M ago
TYRA
Tyra Bioscience Appoints Bhavesh Ashar as COO
PremiumCompany AnnouncementsTyra Bioscience Appoints Bhavesh Ashar as COO
4M ago
8K
TYRA
Tyra Biosciences appoints Ashar as COO, Faulds as CRO
Premium
The Fly
Tyra Biosciences appoints Ashar as COO, Faulds as CRO
4M ago
TYRA
Tyra Biosciences Reports Increased Loss Amid R&D Investments
Premium
Company Announcements
Tyra Biosciences Reports Increased Loss Amid R&D Investments
5M ago
TYRA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >